SEARCH

SEARCH BY CITATION

References

  • 1
    McKhann GM, Knopman DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 2639.
  • 2
    Albert MS, DeKosky SD, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 2709.
  • 3
    Korf ES, Wahlund LO, Visser PJ et al. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63: 94100.
  • 4
    Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. Lancet Neurol 2007; 6: 73446.
  • 5
    Scheltens P, Leys D, Barkhof F et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 96772.
  • 6
    Scheltens P, van de Pol LA. Impact commentaries. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 2012; 1: 103840.
  • 7
    Pereira JB, Cavallin L, Spulber G et al. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med 2014; doi: 10.1111/joim.12148.
  • 8
    Lovestone S, Francis P, Strandgaard K. Biomarkers for disease modification trials–the innovative medicines initiative and AddNeuroMed. J Nutr Health Aging 2007; 11: 35961.
  • 9
    Lovestone S, Francis P, Kloszewska I et al. AddNeuroMed – the european collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci 2009; 1180: 3646.
  • 10
    van de Pol LA, Hensel A, Barkhof F et al. Hippocampal atrophy in Alzheimer disease: age matters. Neurology 2006; 66: 2368.
  • 11
    Visser PJ, Kester A, Jolles J et al. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006; 67: 12017.
  • 12
    van der Flier WM, Pijnenburg YAL, Fox NC et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ε4 allele. Lancet Neurol 2011; 10: 2808.
  • 13
    Snowden JS, Stopford CL, Julien CL. Cognitive phenotypes in Alzheimer's disease and genetic risk. Cortex 2007; 43: 83545.
  • 14
    Boutet C, Chupin M, Colliot O et al. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease? Neuroradiology 2012; 54: 132130.